HLA-DRA and COVID-19: Unlike MCEMP1, which was exclusively differentially expressed in CD14+ cells (Fig. 4c), reduced expression of HLA-DRA could be detected more broadly across other myeloid cells, B cells, T cells, NK cells and platelets, indicating a global suppression of antigen presentation in severe COVID-19 patients (Fig. 4d).